ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES

被引：0
|
作者：
Mennezein, L. [1 ]
Avot, D. [1 ]
Laigle, V [2 ]
机构：
[1] MSD France, Courbevoie, France
[2] MSD Vaccins, Lyon, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.943
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY116
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [1] Patient access to orphan drugs in France
    Marion Bourdoncle
    Blandine Juillard-Condat
    Florence Taboulet
    Orphanet Journal of Rare Diseases, 14
  • [2] Patient access to orphan drugs in France
    Bourdoncle, Marion
    Juillard-Condat, Blandine
    Taboulet, Florence
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [3] HORIZONTAL VS. VERTICAL EQUITY: MARKET ACCESS OF ORPHAN DRUGS IN FRANCE AND UK
    Korchagina, D.
    Tavella, F.
    Remuzat, C.
    Toumi, M.
    Falissard, B.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [4] ORPHAN DRUGS' MARKET ACCESS IN THE UNITED STATES
    Doyle, J. J.
    Sepulveda, B.
    VALUE IN HEALTH, 2009, 12 (03) : A8 - A8
  • [5] ACCESS TO ORPHAN ONCOLOGY DRUGS IN FRANCE VERSUS THE UNITED KINGDOM
    Esmail, S.
    Grosvenor, A. S.
    VALUE IN HEALTH, 2012, 15 (04) : A18 - A18
  • [6] MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS
    Malacan, J.
    Gabriel, S.
    Dinet, J.
    Forget, S.
    Borget, I
    VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [7] MARKET ACCESS OF DRUGS IN FRANCE: EVOLUTION OR REVOLUTION?
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A304 - A304
  • [8] EU to provide incentives for "orphan" drugs
    Watson, R
    BRITISH MEDICAL JOURNAL, 2000, 320 (7245): : 1294 - 1294
  • [9] Orphan drugs in France (2001-2005): Access to information and characteristics
    Baumevieille, Marie
    Daveluy, Amelie
    Aulois-Griot, Marine
    Haramburu, Francoise
    THERAPIE, 2007, 62 (01): : 9 - 16
  • [10] CHANGES TO EARLY ACCESS SCHEME IN FRANCE: EARLY LEARNINGS FOR ORPHAN DRUGS
    Sostar, J.
    Faivre, P.
    Herscu, P.
    VALUE IN HEALTH, 2022, 25 (12) : S242 - S242
12345